CIK: 1706176 - Address: C/O Lenz Therapeutics, Inc., 445 Marine View Ave Suite 320, Del Mar, CA 92014
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/27/24 19:54
2/27/24
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-20.73220-3-3102D
11/28/23 19:06
11/28/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-20.50000-4-499D
8/29/23 18:47
8/28/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-51.450-4-496D
5/26/23 19:29
5/25/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-51.420-4-492D
2/28/23 18:22
2/27/23
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-61.680-4-489D
11/29/22 17:33
11/28/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-102.720-4-486D
8/29/22 21:14
8/26/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-154.020-4-482D
5/27/22 17:27
5/26/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-71.900-4-479D
3/1/22 21:10
2/28/22
VIRXViracta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsChevallard Daniel R.CAOCFO,COOS.d-112.780-4-576D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact